Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Ion Beam Applications S.A.

US

Last updated May 23, 2026

What Ion Beam Applications S.A. makes

The company designs and manufactures proton therapy systems, including the Proteus 235 series (Proteus One, Proteus Plus, Proteus TK2, and Proteus Class) and associated gantry beam lines for targeted cancer treatment. These systems deliver precise radiation doses using proton beams, enabling treatment of complex tumours with reduced exposure to surrounding healthy tissue. Modifications for existing systems are also provided to enhance functionality or compliance. The I2C system is included as part of the therapy infrastructure.

The portfolio is regulated under FDA 510(k) clearance as Class II medical devices. These systems are listed in the FDA’s 510(k) registry. The company is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Ion Beam Applications S.A. manufacture?

Ion Beam Applications S.A. specializes in designing and manufacturing proton therapy systems, primarily the Proteus 235 series (including Proteus One, Proteus Plus, Proteus TK2, and Proteus Class). These systems are used for targeted cancer treatment by delivering precise radiation doses via proton beams, minimizing exposure to healthy tissue. The company also produces gantry beam lines and modifications for existing systems, as well as the I2C system, which supports the therapy infrastructure.

Where is Ion Beam Applications S.A. based?

Ion Beam Applications S.A. is headquartered in the United States. The company’s location influences its regulatory compliance, particularly for devices marketed in the U.S., where its proton therapy systems are subject to FDA oversight.

Which regulatory registries list Ion Beam Applications S.A.’s devices?

Ion Beam Applications S.A.’s proton therapy systems, including the Proteus 235 series and associated components, are listed in the FDA’s 510(k) registry. This registry tracks Class II medical devices that have undergone the FDA’s 510(k) clearance process, demonstrating compliance with applicable safety and performance standards before commercial distribution.

How are Ion Beam Applications S.A.’s devices classified under medical device regulations?

The company’s proton therapy systems, such as the Proteus 235 series and gantry beam lines, are classified as Class II medical devices. This classification is determined by the FDA based on the level of risk associated with the device’s intended use. Class II devices require special controls in addition to general controls to ensure their safety and effectiveness, and they must undergo a 510(k) premarket notification process to demonstrate compliance.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (31)

DeviceModel / ReferenceRegistriesClassStatus
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
Proteus 235 Proteus ONE
FDA UDI
Class IIActive
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
Proteus 235 Proteus PLUS
FDA UDI
Class IIActive
Proteus 235 Proteus PLUS
FDA UDI
Class IIActive
Proteus 235 Proteus PLUS
FDA UDI
Class IIActive
I2C (IBA Image Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
Proteus 235 Proteus ONE
FDA UDI
Class IIActive
IBA Proton Therapy System – Proteus 235 Proteus PLUS/Proteus ONE
FDA UDI
Class IIActive
I2C (IBA Image-Guided Therapy Console) adaPTinsight
FDA UDI
Class IIActive
Iba Proton Therapy System, Model Proteus 235 K100766
FDA 510(k)
Class IIActive
Proton Therapy System K983024
FDA 510(k)
Class IIActive
Gantry Beam Line K132919
FDA 510(k)
Class IIActive
Iba Proton Therapy System - Proteus 235 K083058
FDA 510(k)
Class IIActive
Iba Proton Therapy System- Proteus 235 K082416
FDA 510(k)
Class IIActive
Iba Proton Therapy System, Proteus 235 K092796
FDA 510(k)
Class IIActive
Proteus 235 Proton Therapy System K091629
FDA 510(k)
Class IIActive
Iba Proton Therapy System - Proteus 235 K060695
FDA 510(k)
Class IIActive
Modification To Iba Proton Therapy System-Proteus 235 K101508
FDA 510(k)
Class IIActive
I2c K132847
FDA 510(k)
Class IIActive
Iba Proton Therapy System - Proteus 235 K061913
FDA 510(k)
Class IIActive
Proton Therapy System - Proteus 235 (Proteus One, Proteus Plus, Proteus TK2) K152224
FDA 510(k)
Class IIActive
IBA Proton Therapy System- Proteus 235 (Proteus One, Proteus Plus, Proteus TK2, Proteus Class) K163500
FDA 510(k)
Class IIActive
Iba Proton Therapy System-Proteus 235 K053641
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Ion Beam Applications S.a. LOUVAIN-LA-NEUVE, BE Brabant Wallon · BE FEI 3000256071